Results 171 to 180 of about 227,189 (359)

Somatic cell reprogramming for Parkinson's disease treatment

Ibrain, Volume 11, Issue 1, Page 59-73, Spring 2025.
The fundamental purpose of cell reprogramming to treat Parkinson's disease is to generate dopaminergic neurons (DAN) and do transplantation. There are two ways to accomplish this. One method is to induce cells into induced DA neurons (iDAN) directly or to induce cells into induced pluripotent stem cells and ultimately into iDAN in vitro. Another option
Xiaozhuo Li, Kevin Fang, Fengping Wang
wiley   +1 more source

Activation of Skeletal Muscle Phosphorylase Kinase by Adenosine Triphosphate and Adenosine 3′,5′-Monophosphate

, 1968
R J DeLange, Richard Kemp, William D. Riley, R.A. Cooper, E G Krebs   +4 more
openalex   +1 more source

Effects of glucagon on adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in human plasma and urine [PDF]

, 1970
Arthur E. Broadus, Neil I. Kaminsky, Robert C. Northcutt, Joel G. Hardman, Earl W. Sutherland, Grant W. Liddle   +5 more
openalex   +1 more source

The mechanisms in glucose metabolism of aging hippocampus

Ibrain, EarlyView.
Cognitive decline in elders stems from the irreversible loss and functional decline of neurons, with the hippocampus being particularly susceptible to age‐related neuronal deterioration. Glucose acts as the primary fuel for the brain, and a constant provision of glucose to the hippocampus is essential for memory and cognitive functions.
Rui He, Fuxing Zhao, Zhiyu Yang, Tingting Wang, Yaohui Zhang, Jinglan Quan, Gaohong Zhu   +6 more
wiley   +1 more source

Cyclic adenosine monophosphate potentiates immune checkpoint blockade therapy in acute myeloid leukemia. [PDF]

Clin Transl Med, 2023
Mao P, Feng W, Zhang Z, Huang C, Zhou S, Zhao Z, Mu Y, Zhao AY, Wang L, Li F, Zhao AZ.   +10 more
europepmc   +1 more source

An Adenosine 3′,5′-Monophosphate-dependent Protein Kinase from Escherichia coli

, 1969
J.F. Kuo, Paul Greengard
openalex   +1 more source

Regulation of Adenosine 3′:5′-Cyclic Monophosphate Concentration in Cultured Human Astrocytoma Cells by Catecholamines and Histamine [PDF]

, 1971
Richard B. Clark, John P. Perkins
openalex   +1 more source

Targeting aerobic glycolysis combats tyrosine kinase inhibitor resistance of hepatocellular carcinoma

International Journal of Cancer, EarlyView.
Abstract Hepatocellular carcinoma (HCC) represents the predominant form of primary liver cancer and is frequently identified at a late stage, necessitating systemic therapy. However, resistance to first‐line tyrosine kinase inhibitor therapies, such as sorafenib and lenvatinib, remains a significant clinical challenge.
Longtao Zhao, Junjie Cheng, Yiming Zheng, Jing Wu, Jia Fan, Haixiang Sun, Chao Gao   +6 more
wiley   +1 more source

Effects of Cyclic Adenosine Monophosphate Nanoliposomes on Growth Performance, Gut Development and Microbiota of Broilers. [PDF]

Animals (Basel)
Chen L, Wang L, Huang S, Su G, Jiang S, Yang F, Huang J.   +6 more
europepmc   +1 more source

Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer's disease prevention. [PDF]

Neural Regen Res, 2023
Gopalakrishna R, Oh A, Bhat NR, Mack WJ.
europepmc   +1 more source